CORNEAL TOPOGRAPHY/TOMOGRAPHY EXPLAINED

How to read and interpret the wealth of information and data provided by Pentacam maps

By Anastasios John Kanellopoulos, MD

CROSSING OUT KERATOCONUS WITH CXL

Perspectives on who to treat and other considerations.

By Joseph F. Jalkiewicz, contributing writer

INCORPORATE AN NK DRUG INTO YOUR PRACTICE

When and how to use Oxervate for the treatment of neurotrophic keratitis.

By OLIVIA L. LEE, MD

VISUAL REHABILITATION FOR KERATOCONUS

Go beyond slowing or stopping progression.

By Kenneth Beckman, MD, FACS

PEARLS FOR ACANTHAMOEBA KERATITIS

How to diagnose and manage this challenging infection

By RAHUL TONK, MD, MBA, DANIELA P. REYES-CAPÓ, MD

WHAT’S NEW IN PEDIATRICS AND STRABISMUS

Discoveries and treatments of visual system diseases in infants and children over the last quarter century.

By RICHARD W. HERTLE, MD, FAAO, FACS, FAAP

GUEST EDITORIAL

STRAIGHT FROM THE EXPERTS

By Alanna Nattis, DO, FAAO

VIEWPOINT FROM THE EDITOR

WHEN THE DOCTOR BECOMES THE PATIENT

By Lisa K. Feulner, MD, PhD

CODING & REIMBURSEMENT

BEWARE THE EO/IMAGING OVERLAP

By Suzanne L. Corcoran, COE

QUICK HITS

SOCIAL MEDIA HACKS

PITFALLS OF SOCIAL MEDIA

By Dagny Zhu, MD

FINANCIAL FACTOR

OF DESIGN PRINCIPLES AND THE ETERNAL QUESTION

By Scott LaBorwit, MD

SPOTLIGHT ON TECHNOLOGY & TECHNIQUE

EDUCATING A NEW GENERATION OF TECHNICIANS

By Karen Appold, contributing writer

INDUSTRY INSIDER

OCUPHIRE PHARMA’S MINA SOOCH

LESSONS LEARNED

FOCUS ON THE PATIENT EXPERIENCE

By FAHEEM AHMED, MD